Valneva SE SEC filings VALN

Valneva SE has 269 filings in SEC EDGAR's recent list, going back to Jan 15, 2021. Its latest annual report, Form 20-F, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 6, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
424B3 Prospectus Jun 16, 2026 —
F-3 Shelf registration (foreign issuer) Jun 4, 2026 —
F-3 Shelf registration (foreign issuer) Mar 25, 2025 —
424B5 Prospectus supplement Sep 30, 2022 —
424B5 Prospectus supplement Sep 29, 2022 —
F-3 Shelf registration (foreign issuer) Aug 12, 2022 —
424B4 Prospectus Nov 1, 2021 —
F-1 Registration statement (foreign issuer) Oct 26, 2021 —
424B4 Prospectus May 7, 2021 —
F-1/A Filing May 5, 2021 —
F-1/A Filing Apr 29, 2021 —
F-6/A Filing Apr 23, 2021 —
F-1/A Filing Apr 21, 2021 —
F-6 Filing Apr 16, 2021 —
F-1 Registration statement (foreign issuer) Apr 9, 2021 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VALN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
France
Headquarters
Saint-Herblain, France
SEC filer status
Accelerated filer
SEC CIK
1836564

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.